Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
about
Conjugate vaccines for preventing meningococcal C meningitis and septicaemiaConjugate vaccines for preventing meningococcal C meningitis and septicaemiaMucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Meningococcal serogroup C conjugate vaccine.The msbB mutant of Neisseria meningitidis strain NMB has a defect in lipooligosaccharide assembly and transport to the outer membrane.Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults.Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine.Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children.Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.Neisseria meningitidis serogroup A vaccines: an overview.Recent developments in Neisseria meningitidis group A conjugate vaccines.Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.Can mucosal adjuvants contribute to the induction of immunological memory induced via unconjugated T-cell-independent antigens?Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
P2860
Q24235722-13EC152C-20D4-40E6-82BE-1DBB7E910E93Q24244951-AC0090F4-59E4-468F-B241-28319A794D56Q28187952-A55DD3DD-DFE0-457A-925A-F9AABF92E391Q34170021-BF441C9D-7335-4330-A8C4-D0FF93C49B9EQ34482078-EF074E97-2B58-4D72-A483-5E8F95744A2DQ34581610-8535F7F5-0521-44C8-B297-F8F9841CCADBQ34738958-A1FCD174-77B9-4AB4-801F-BF964957F0FBQ35013077-A0AF4EA2-87F5-43DF-A5CC-FC44DEBDF29CQ35531214-A487E1B4-860D-4B95-B11F-3BC69538F686Q35588006-DE08666B-2B23-4EC1-9710-63D4813FDBECQ35623344-37B296A3-8049-42DB-A541-ADE74B84C31FQ36065978-47085C3D-9F63-4643-9AA7-DACC3254A1E0Q36154043-5360F350-024D-4071-B55A-560F32A008E7Q36600323-18BB7F93-4CD5-4646-902E-BADEB3BDBCD5Q38013202-FE986EC6-1EF2-4857-9F63-6B63BFD70001Q53762383-D0C1DD28-1D16-4410-8565-BC17DAA41BBEQ54963381-D38C9A1B-79C0-48F6-8A70-952F8D94FBF0
P2860
Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Primary and booster mucosal im ...... tudents in the United Kingdom.
@en
Primary and booster mucosal im ...... tudents in the United Kingdom.
@nl
type
label
Primary and booster mucosal im ...... tudents in the United Kingdom.
@en
Primary and booster mucosal im ...... tudents in the United Kingdom.
@nl
prefLabel
Primary and booster mucosal im ...... tudents in the United Kingdom.
@en
Primary and booster mucosal im ...... tudents in the United Kingdom.
@nl
P2093
P2860
P1476
Primary and booster mucosal im ...... tudents in the United Kingdom.
@en
P2093
R Burkinshaw
R Lakshman
P2860
P304
P356
10.1128/IAI.69.7.4337-4341.2001
P407
P577
2001-07-01T00:00:00Z